Atlas Trials

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Clinical trial NCT00363831 · UNKNOWN

Trial details

NCT number
NCT00363831
Sponsor
The University of Hong Kong
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Neoplasms
Start date
2006-07-01
Primary completion
2009-12-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.